Aker Christopher Ray Insider Trades

Insider Trading History

Track insider trading activity for Aker Christopher Ray. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $678k 83,125 shares
Last Trade
Jun 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$496k 60,796 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.8M 1,448,500 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $3.98M 487,500 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 487,500 shares
$1.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $404k 49,546 shares
Last Trade
Jan 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.41k 5,088 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $446k 54,634 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.6k 38,547 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $760k 93,181 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 84,125 shares
$1.35
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $2.96M 363,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$730k 363,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $82.1k 10,056 shares
Last Trade
Jan 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.51k 5,468 shares
$1.19
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $571k 70,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91k 70,000 shares
$1.30
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $3.21M 393,750 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$536k 393,750 shares
$1.36
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $571k 70,000 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 70,000 shares
$1.72
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $3.92M 480,000 shares
Last Trade
Jan 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 480,000 shares
$2.57
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $341k 41,754 shares
Last Trade
May 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.78k 860 shares
$9.05
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $348k 42,614 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.1k 828 shares
$19.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $1.47M 180,000 shares
Last Trade
Feb 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.86M 180,000 shares
$15.90
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $210k 25,762 shares
Last Trade
Nov 16, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.78k 876 shares
$5.46
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $217k 26,638 shares
Last Trade
Aug 14, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.32k 872 shares
$6.10
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $224k 27,510 shares
Last Trade
May 15, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.44k 909 shares
$5.99
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $232k 28,419 shares
Last Trade
Feb 18, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.37k 888 shares
$8.30
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Sr. VP & General Counsel
Holding Value $1.71M 210,000 shares
Last Trade
Jan 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75M 210,000 shares
$13.10
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up